(Circulation. 2001;103:1858.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Saline-Cooled Versus Standard Radiofrequency Catheter Ablation for Infarct-Related Ventricular Tachycardias
From the Cardiovascular Division, Department of Internal Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.
Correspondence to William G. Stevenson, MD, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115. E-mail wstevenson{at}rics.bwh.harvard.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Background—Saline cooling of the electrode during radiofrequency (RF) ablation increases lesion size in animal models. If cooled RF also increases lesion size in human infarcts, it should facilitate the termination of ventricular tachycardia (VT).
Methods and Results—In 66 patients with VT due to prior infarction, 366 ablation sites, which were classified by entrainment and isolated potentials followed by ablation during VT with either standard RF energy (247 sites) or cooled RF (119 sites), were retrospectively reviewed to compare the efficacy for terminating VT. RF energy was applied at 259 isthmus sites, 62 bystander sites, 28 inner loop sites, and 17 outer loop sites. Compared with standard RF, cooled RF terminated VT more frequently at isthmus sites where an isolated potential was present (89% versus 54%, P=0.003), isthmus sites without an isolated potential (36% versus 21%, P=0.04), and at inner loop sites (60% versus 22%, P=0.04). Termination rates were similarly low for cooled and standard RF at bystander sites (14% versus 9%, P=0.56) and outer loop sites (13% versus 11%, P=0.93).
Conclusions—Greater efficacy of cooled RF for terminating VT is consistent with the production of a larger lesion in human infarctions, which should facilitate successful ablation.
Key Words: tachycardia • ablation • reentry
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Ablation of ventricular tachycardia (VT) associated with myocardial infarction can be challenging. The reentry circuits can be large, and portions of the reentry path can be located deep to the endocardium.1 2 3 Multiple radiofrequency (RF) lesions are often required, and inadequate lesion size likely contributes to failures. For any given electrode size and tissue contact area, RF lesion size is a function of RF power and duration of application. These parameters are limited when the tissue electrode interface reaches 100°C and denatured proteins form a coagulum on the electrode catheter, increasing impedance. Cooling the electrode by saline irrigation helps to prevent coagulum formation and allows the creation of deeper and larger lesions in animal models. If saline-cooled RF ablation increases lesion size in human infarcts, it should facilitate termination of VT during RF ablation. The 2 methods of ablation have not been directly compared for VT ablation in humans.
Termination of sustained VT by an RF application indicates that conduction has been interrupted through a portion of the reentry circuit.3 4 We hypothesized that if saline-irrigated ablation produced larger lesions in vivo in human infarct regions, it would be more effective in interrupting VT compared with standard RF ablation. Therefore, the effect of cooled RF ablation and standard RF ablation on induced, sustained VT was compared in patients undergoing VT ablation after infarction. The location of the RF site relative to the reentry circuit was characterized by entrainment and analysis of isolated potentials; therefore, the 2 types of ablation were compared at similar types of sites, including isthmus sites where termination is often achieved and in reentry circuit loops and bystander regions, where termination of VT is more difficult.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
A retrospective analysis of data from a total of 66 patients with recurrent VT after myocardial infarction who were referred for catheter ablation was performed. Patients had to meet the following criteria: (1) sustained, monomorphic VT was present or inducible in the electrophysiology laboratory, and (2) pacing for entrainment was performed at a mapping site followed immediately by application of RF current for ablation, allowing assessment of whether VT terminated during the RF application.3 4 Patient characteristics are shown in Table 1
.
|
Mapping and ablation using the investigational ablation systems were performed according to protocols approved by the institutional review boards of Brigham and Women’s Hospital, Boston, Mass, after informed consent was obtained. The mapping and ablation approach has been previously described.3 4 Access to the left ventricle was achieved with a retrograde aortic or trans-septal approach. Systemic anticoagulation was maintained with the intravenous administration of heparin. Bipolar electrograms were filtered at 30 to 500 Hz and recorded along with the 12-lead ECG of all induced VTs (Prucka Engineering Inc). After introducing the catheters, the area of infarction was identified on the basis of the location of abnormal electrograms. If VT was not incessant, tachycardia was then initiated and mapping continued during monomorphic VT, if tolerated. If VT was poorly tolerated, repeated initiation and termination were used to allow limited mapping during tachycardia. We initially sought reentry circuit isthmus sites for ablation.
When RF application terminated VT at a site, additional
lesions were applied to the region within 
1 cm of the termination
site until unipolar pacing at the stimulus strength initially tested
(usually 10 mA, 2-ms pulse width) failed to capture at the site. When
isthmus sites were not identified, RF lesions were placed at outer loop
or bystander sites. Programmed stimulation was then used to induce VT
for further mapping and ablation of other circuits. The end point of
the procedure was the absence of inducible VT, no reentry circuit sites
identified on the endocardium, or only rapid, poorly tolerated,
inducible VT that was different in rate and morphology than the VT
induced at the beginning of the procedure.
Standard RF ablation was performed using an 8-French catheter with a 4-mm tip electrode (EPT, Boston Scientific or Biosense Webster) in 46 patients. RF energy application was initiated at 20 to 30 W, and the power was gradually increased to achieve a measured electrode tip temperature of 60 to 65°C, an impedance fall of 6 to 10 Ohms, or a maximum power of 50 Watts. The electroanatomical mapping system was used to track catheter position in 7 patients with the external irrigation system and in 19 patients with standard RF.
Cooled RF ablation was performed using 1 of 2 systems in 20 patients. In 7 patients, an external irrigation system was used (Thermocool, Biosense Webster). This 8-French catheter has an electrode 3.5 mm in length with 6 holes in the tip through which saline flows at 30 mL/min during RF application. In 13 patients, an internal irrigation system was used (Chilli Cool Catheter, Cardiac Pathways). Saline flows at 36 mL/min through the electrode and returns through a second lumen to be discarded outside the patient. For both cooled RF systems, application was initiated after saline irrigation decreased the measured electrode temperature to 28 to 32°C. Initial power was 20 to 30 W, and the power was gradually increased to achieve a fall in impedance of 5 to 10 Ohms or a maximal measured electrode tip temperature of 40 to 45°C. Energy application was continued for a minimum of 30 seconds and a maximum of 2 minutes. RF current application was discontinued if measured impedance increased by >10 Ohms, the catheter changed position, or VT failed to terminate after 30 to 60 seconds.
Before RF current application, entrainment was used to
determine the relation of the site to the reentry
circuit.3 Entrainment used
unipolar stimuli at a stimulus strength of 10 mA and 2 ms pulse width,
which increased to pulse widths of 5 or 9 ms if needed for capture.
Sites were designated as being in the reentry circuit if the postpacing
interval was within 30 ms of the tachycardia cycle length
or if the S-QRS interval during entrainment with concealed fusion was
within 20 ms of the electrogram to QRS interval. Isthmus sites are
defined as those that are in the circuit where entrainment occurs with
concealed fusion and with a stimulus to the QRS (S-QRS) interval that
was 
70% of the tachycardia cycle length. Outer loop
sites are circuit sites where entrainment occurs with QRS fusion. Inner
loop sites are in the circuit but have a S-QRS >70% of the VT cycle
length during entrainment with concealed fusion. Bystander sites are
outside the circuit.3 Sites
were further grouped into those with and without an isolated potential
present during
VT.5 6
At the end of the procedure, programmed stimulation was used to determine the early results of ablation. Stimulation included burst pacing and 1 to 3 extrastimuli after drive trains of 2 different cycle lengths from 2 different right ventricular sites. Early results were defined as no inducible VT, modified VT (a faster new VT is induced), and failure to abolish inducible VTs that were targeted for ablation. Previously ineffective antiarrhythmic agents were continued (in the absence of toxicity) before and after ablation when required by investigational device protocols or when amiodarone had been administered long-term before ablation. Follow-up was obtained for all patients in May 2000.
Statistics
Results are expressed as mean±SD. Unpaired
t tests and
2 tests were used for comparisons with
the null hypothesis discarded at
P<0.05. Time-to-event survival
curves were constructed using the Kaplan-Meier method and compared with
the Mantel-Cox method.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Short-Term Effects
Data from a total of 366 sites evaluated during 89 different VTs that met the inclusion criteria were analyzed. There were 259 isthmus sites, 62 bystander sites, 28 inner loop sites, and 17 outer loop sites. RF termination was more frequent at isthmus sites (36%) than at other types of sites (18%), and it was more frequent at isthmus sites where an isolated potential was also present (67%) than at isthmus sites without isolated potentials (24%, P<0.0001).
Standard RF current application terminated VT at 62 sites
(25%), and cooled RF current application terminated VT at 51 sites
(43%, P=0.0006). At isthmus
sites, cooled RF terminated VT more frequently than standard RF
ablation
(Table 2). For isthmus sites where an isolated potential was
present, cooled RF terminated VT more frequently than standard RF
(89% versus 54%, P=0.003).
Cooled RF was also more effective than standard RF at isthmus sites
where an isolated potential was absent (36% versus 21%,
P=0.04) and at inner loop sites
(60% versus 22%, P=0.04). At
outer loop (13% versus 11%,
P=0.93) and bystander sites
(14% versus 9%, P=0.56),
cooled RF and standard RF had a similarly low efficacy
(Table 2).
|
Table 3 compares the average maximal power achieved. As
anticipated, the maximal power achieved was greater with cooled than
with standard RF
(Figure 1). Within the cooled RF group, maximal power
was similar for sites where RF application terminated VT and for sites
where RF failed to terminate VT
(Table 3). Similarly, in the standard RF group, similar
power was applied to the sites where termination of VT occurred and in
those where RF failed to terminate VT. In the cooled RF group, ablation
at an isthmus site with the external irrigation catheter
(Thermocool) resulted in termination more
frequently than with the internal saline irrigation catheter
(Chilli Cool Catheter) (16 of 17 sited [94%]
versus 27 of 55 sites [50%],
P=0.0026). This difference
could be related to the greater maximal power applied (40.2±4.2 versus
37.7±4.6 W with external versus internal irrigation,
P=0.05) and longer total
duration of RF application with the external irrigation catheter
compared with the internal irrigation catheter (115.4±14.9 versus
74.5±31.8 s, P<0.0001).
However, at sites with termination, the time to termination of VT was
shorter with external irrigation than with internal irrigation
(28.1±34.0 versus 51.9±29.0 s,
P=0.01).
|
|
In the standard RF group, power delivery was guided by a fall in impedance in 56 applications using catheters without temperature sensors and by temperature monitoring in 253 applications using temperature-controlled RF application. With both temperature monitoring and impedance monitoring, the frequency of impedance rises (6 of 253 sites [2.4%] versus 2 of 56 sites [3.6%], P=0.62) and the incidence of VT termination (61 of 253 sites [24.1%] versus 16 of 56 sites [28.6%], P=0.49) were similar.
A total of 26.3±20.4 standard RF applications and 20.8±12.1 cooled RF applications were applied per patient. Standard RF ablation abolished all inducible, monomorphic VTs in 21 of 46 patients (46%), modified inducible VT in 14 patients (30%), and failed to abolish an inducible targeted VT in 11 patients (24%). Cooled RF ablation abolished all inducible monomorphic VTs in 9 of 20 patients (45%), modified inducible VT in 8 patients (40%), and failed to abolish a targeted VT in 3 patients (15%). The early success rate (abolished inducible VT or modified inducible VT) for cooled RF was 85%, and for standard RF, 76% (P=0.85).
Complications occurred in 4 patients in the standard RF group (2 femoral artery dissections, 1 small peripheral arterial embolism that did not require therapy, and 1 retroperitoneal hematoma that required transfusion) and in 2 patients with cooled RF (1 femoral artery dissection that did not require intervention and 1 aortic valve injury with aortic insufficiency discovered at coronary artery bypass surgery).
Follow-Up
During follow-up, previously ineffective antiarrhythmic
agents were continued in 55% of the standard ablation and 65% of the
cooled ablation groups. All but 10 patients had an implanted
cardioverter defibrillator. During a mean follow-up of 530±495 days
(range, 4 to 1916 days), VT recurred spontaneously in 35% of the
standard RF ablation patients and in 10% of the cooled RF ablation
patients (P=0.07,
Figure 2). Average time to VT recurrence was 93±159
days (range, 1 to 294 days). Mortality was similar in the 2 groups. In
the cooled RF group, 3 patients (15%) died (from pulmonary
embolism after hip fracture, cancer, and pneumonia, respectively) and 1
patient underwent cardiac transplantation. In the standard RF group, 11
patients (28%) died (7 of congestive heart failure, 1 of stroke, 2 of
sepsis, and 1 of liver failure, respectively) and 3 patients underwent
cardiac transplantation.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
This is the first study comparing saline-cooled RF ablation with standard RF ablation in patients with VT due to prior myocardial infarction. Cooled RF ablation was more effective in terminating VT in the short-term, which is consistent with the production of a larger lesion, as seen in prior studies in animal models, in vitro preparations, and anecdotal observations.7 8 9 10 11 Ablation was most effective at sites identified as likely isthmuses on the basis of entrainment and the presence of an isolated potential, as was previously reported.5 In the present study, the termination rate at isthmus sites was significantly higher in the cooled RF group, suggesting that these reentry circuit isthmuses often exceed the width and depth of a standard RF lesion.
The ideal comparison of cooled and standard RF ablation would be a prospective, randomized study. Our patients who received cooled RF were enrolled in US Food and Drug Administration–approved studies when this technology was investigational. A randomized trial was not possible. Subsequently, one of these systems (Chilli Cool Catheter, Cardiac Pathways) was approved by the agency, and ongoing investigation of the other system is continuing. To reduce confounding factors in our retrospective analysis, we took several precautions. Termination of VT during RF application was used as the end point for assessing effect, as described previously.3 4 5 The efficacy of termination was compared for identical types of sites, as identified by entrainment and the presence of isolated potentials. The duration of RF application at sites without termination was analyzed and found to be similar for the cooled and standard RF applications.
During follow-up, the incidence of recurrent VT tended to be lower, although statistical significance was not reached. Comparison of early success rates with previous studies12 13 is difficult because success is often reported as the ablation of a "targeted" or "clinical" VT, without regard to the presence of other inducible VTs. The efficacy of standard RF was similar to that observed in a previous study of 52 patients from our group.4 Standard RF abolished all inducible VT in 40% of patients and modified inducible VTs in 31% of patients; recurrence rate after 3 years of follow-up was 33% and the survival rate was 70%. In the present study, 85% of patients were rendered free of inducible VT or had modified VT with cooled RF ablation. During follow-up, the recurrence rate was 35% in the standard RF group and 10% in the cooled RF group. The Cooled RF Multicenter Investigators group,14 which included 10 of the patients reported in this study among their 146 total patients, reported a 75% success rate of cooled RF and a recurrence rate during follow-up of 40%.
Limitations
There are a number of limitations to this study. The
protocols for cooled RF systems precluded randomization of patients or
lesion sites. A number of differences between RF ablation systems makes
comparison of power and energy between different ablation systems
difficult. The power reported by the generator indicates only a
fraction of the power that is dissipated as heat in the tissue due to
variations in system impedance, loss along the cables, and other
factors.9 Our system for
internal saline irrigation stored only the maximal power, impedance,
and temperature for later retrieval. Therefore, we compared only the
maximal values among systems, recognizing that this is only a crude
indication of the energy applied. Methods for standard RF energy
application guided by
temperature15 16
or impedance monitoring have been well defined, and both methods
yielded similar effects in the present study. The optimal manner of
energy titration for cooled RF application has not been clearly
defined. Whether the systematic method used in this study is the
optimal method of energy delivery for maximizing lesion size is not
known. We also applied the same methods of RF current application with
both the internal and external saline irrigation systems, despite the
differences between the 2 systems. Finally, we do not have anatomic,
histological documentation of lesion size with the
different methods.
|
Conclusions |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
Cooled RF ablation terminates reentrant VT more effectively than standard RF, which is consistent with the production of larger lesions in human infarctions. Saline-cooled RF ablation is a promising technology for facilitating the ablation of large reentry circuits.
|
Acknowledgments |
|---|
A portion of this work was supported by a grant from Biosense-Webster.
Received September 18, 2000; revision received December 31, 2000; accepted January 11, 2001.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionConclusionsReferences |
|---|
1. de Bakker JMT, van Capelle FJL, Janse MJ, et al. Macroreentry in the infarcted human heart: mechanism of ventricular tachycardias with a focal activation pattern. J Am Coll Cardiol. 1991;18:1005–1014.[Abstract]
2.
Kaltenbrunner W,
Cardinal R, Dubuc M, et al. Epicardial and endocardial mapping of
ventricular tachycardia in patients with
myocardial infarction: is the origin of the tachycardia
always subendocardially localized?
Circulation.. 1991;84:1058–1071.
3. Stevenson WG, Friedman PL, Sager PT, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29:1180–1189.[Abstract]
4.
Stevenson WG,
Friedman PL, Kocovic D, et al. Radiofrequency catheter ablation of
ventricular tachycardia after myocardial
infarction. Circulation. 1998;98:308–314.
5.
Kocovic DZ, Harada
T, Friedman PL, et al. Characteristics of electrograms recorded at
reentry circuit sites and bystanders during ventricular
tachycardia after myocardial infarction.
J Am Coll Cardiol. 1999;34:381–388.
6. Bogun F, Knight B, Goyal R, et al. Discrete systolic potentials during ventricular tachycardia in patients with prior myocardial infarction. J Cardiovasc Electrophysiol. 1999;10:364–369.[Medline] [Order article via Infotrieve]
7. Bogun F, Bahu M, Knight BP, et al. Response to pacing at sites of isolated diastolic potentials during ventricular tachycardia in patients with previous myocardial infarction. J Am Coll Cardiol. 1997;30:505–513.[Abstract]
8. Delacretaz E, Stevenson WG, Winters GL, et al. Ablation of ventricular tachycardia with a saline-cooled radiofrequency catheter: anatomic and histologic characteristics of the lesions in humans. J Cardiovasc Electrophysiol. 1999;10:860–865.[Medline] [Order article via Infotrieve]
9. Ruffy R, Imran MA, Santel DJ, et al. Radiofrequency delivery through a cooled catheter tip allows the creation of larger endomyocardial lesions in the ovine heart. J Cardiovasc Electrophysiol. 1995;6:1089–1096.[Medline] [Order article via Infotrieve]
10.
Nakagawa H,
Yamanashi WS, Pitha JV, et al. Comparison of in vivo tissue temperature
profile and lesion geometry for radiofrequency ablation with a
saline-irrigated electrode versus temperature control in a canine thigh
muscle preparation.
Circulation. 1994;91:2264–2273.
11. Skrumeda LL, Mehra R. Comparison of standard and irrigated radiofrequency ablation in the canine ventricle. J Cardiovasc Electrophysiol. 1998;9:1196–1205.[Medline] [Order article via Infotrieve]
12. Mittleman RS, Huang SKS, De Guzman WT, et al. Use of the saline infusion electrode catheter for improved energy delivery and increased lesion size in radiofrequency catheter ablation. Pacing Clin Electrophysiol. 1998;18:1022–1027.
13.
Rothman SA, Hsia
HH, Cossu SF, et al. Radiofrequency catheter ablation of postinfarction
ventricular tachycardia.
Circulation. 1997;96:1525–1531.
14. Gonska BD, Cao K, Schaumann A, et al. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J Am Coll Cardiol. 1994;24:1506–1514.[Abstract]
15.
Calkins H,
Epstein A, Packer D, et al. Catheter ablation of
ventricular tachycardia in structural heart
disease using cooled radiofrequency energy: results of a prospective
multicenter study. J Am Coll
Cardiol. 2000;35:1905–1914.
16. Harvey M, Kim Y-N, Sousa J, et al. Impedance monitoring during RF catheter ablation in humans. Pacing Clin Electrophysiol. 1992;15:22–27.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF]
|
|
|
|
|
|
M. Linhart, H. Mollnau, A. Bitzen, S. Wurtz, J. W. Schrickel, R. Andrie, F. Stockigt, C. Weiss, G. Nickenig, L. M. Lickfett, et al. In vitro comparison of platinum-iridium and gold tip electrodes: lesion depth in 4 mm, 8 mm, and irrigated-tip radiofrequency ablation catheters Europace, May 1, 2009; 11(5): 565 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Stevenson, D. J. Wilber, A. Natale, W. M. Jackman, F. E. Marchlinski, T. Talbert, M. D. Gonzalez, S. J. Worley, E. G. Daoud, C. Hwang, et al. Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial Circulation, December 16, 2008; 118(25): 2773 - 2782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sacher, U. B. Tedrow, M. E. Field, J.-M. Raymond, B. A. Koplan, L. M. Epstein, and W. G. Stevenson Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 153 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF]
|
|
|
|
|
|
W. G. Stevenson and K. Soejima Catheter Ablation for Ventricular Tachycardia Circulation, May 29, 2007; 115(21): 2750 - 2760. [Full Text] [PDF]
|
|
|
|
|
|
M. Volkmer, F. Ouyang, F. Deger, S. Ernst, M. Goya, D. Bansch, K. Berodt, K.-H. Kuck, and M. Antz Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation. Europace, November 1, 2006; 8(11): 968 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Soejima and W. G. Stevenson Ventricular Tachycardia Associated With Myocardial Infarct Scar: A Spectrum of Therapies for a Single Patient Circulation, July 9, 2002; 106(2): 176 - 179. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Triedman, M. E. Alexander, B. A. Love, K. K. Collins, C. I. Berul, L. M. Bevilacqua, and E. P. Walsh Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1827 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.J. Schilling Can catheter ablation cure post-infarction ventricular tachycardia? Eur. Heart J., March 1, 2002; 23(5): 352 - 354. [Full Text] [PDF]
|
|
|
|
 |
|
 New Form of RF Catheter Ablation for VT Patients with Prior MI Journal Watch Cardiology, July 6, 2001; 2001(706): 11 - 11. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||